HK Stock Market Move | BAYZED HEALTH (02609) fell more than 6% during trading; lock-up period for cornerstone investors is nearing expiry.
Baize Medical (02609) fell more than 6% during trading, with the current stock price having dropped more than 50% from its peak in September.
BAYZED HEALTH (02609) fell more than 6% intra-day, with the current stock price down more than 50% from its high point in September. As of the time of writing, it fell 5.24%, trading at HK$4.34 with a turnover of HK$25.2952 million.
On the news front, the lock-up period for BAYZED HEALTH cornerstone investors is about to expire. According to the company's previous announcement, Harvest Oriental SP, one of its cornerstone investors, must adhere to the lock-up commitment until December 23, 2025, and approximately 35.3178 million shares will be unlocked. In the first half of this year, BAYZED HEALTH achieved a revenue of RMB 575 million, a year-on-year increase of about 0.7%; and an adjusted net profit of RMB 9.4 million, a year-on-year increase of about 72.8%.
Related Articles

Shandong Xinhua Pharmaceutical (000756.SZ) has obtained the registration certificate for the suspension of Oseltamivir phosphate and Oseltamivir.

CTF SERVICES (00659) issued 7,043,800 shares under the dividend-in-kind plan.

PLAYMATES TOYS (00869): The main licensing agreement will not be renewed from 2027.
Shandong Xinhua Pharmaceutical (000756.SZ) has obtained the registration certificate for the suspension of Oseltamivir phosphate and Oseltamivir.

CTF SERVICES (00659) issued 7,043,800 shares under the dividend-in-kind plan.

PLAYMATES TOYS (00869): The main licensing agreement will not be renewed from 2027.

RECOMMEND





